The Renilla Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express Renilla luciferase under a CMV promoter (Figure 1: 79565-P, Figure 2: 79565-G).
Figure 1. Schematic of the lenti-vector used to generate the Renilla lentivirus with puromycin selection (BPS Bioscience, #79565-P):
Figure 2. Schematic of the lenti-vector used to generate the Renilla lentivirus with G418 selection (BPS Bioscience, #79565-G):
Two vials (500 μl x 2) of Renilla luciferase lentivirus at a titer ≥5 x 106 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Formulation
The lentiviruses were produced from HEK293T cells in medium containing 90% DMEM + 10% FBS.
References
1. Pessara, U., Koch, N. (1990) Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-κB-like factor to a promoter element. Mol Cell Biol. 10(8):4146-4154.
2. Baeuerle, P.A. (1998) Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr Biol. 8(1):R19-R22.
Storage/Stability
Lentiviruses are shipped with dry ice. For long term storage, it is recommended to store the virus at -80°C. Avoid repeated freeze-thaw cycles. Titers can drop significantly with each freeze-thaw cycle.
Instructions for Use
See product datasheet
Shipping Temperature
-80°C
Warnings
None of the HIV genes (gag, pol, rev) will be expressed in the transduced cells, as they are expressed from packaging plasmids lacking the packing signal. Although the pseudotyped lentiviruses are replication-incompetent, they require the use of a Biosafety Level 2 facility. BPS recommends following all local federal, state, and institutional regulations and using all appropriate safety precautions.